AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesNCT07681193

Effects of Whole Body Vibration on Quadriceps Function, Landing Biomechanics, and Performance in Individuals With ACL Reconstruction

A study testing Whole body vibration (WBV) in people with Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, run by University of North Carolina, Chapel Hill at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Individuals who undergo anterior cruciate ligament reconstruction (ACLR) are at heightened risk of secondary anterior cruciate ligament (ACL) injury (e.g. additional injury to the ACL in either knee). One of the primary physiological consequences of ACLR is the presence of quadriceps dysfunction (i.e. Read more about this study

Who is it for?
Ages 18 to 35 years
What is being tested?
Whole body vibration (WBV)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteUnited States
Study dates
1 Sep 2021to 10 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Between the ages of 18-35
  • History of primary, unilateral ACLR
  • Medically cleared for unrestricted physical activity

Who cannot join

  • More than 5 years removed from ACLR
  • Currently pregnant
  • History of other lower extremity surgery
  • History of lower extremity injury in previous 6 months
  • History of neurological disorder
  • Maximal isometric quadriceps torque > 3.0 Nm/kg in the ACLR limb

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Univesrity of North Carolina at Chapel HIll MOTION Science Institute

    Chapel Hill, North Carolina, 27599

Other trials in United States

About this study

Official title: Use of Whole-body Vibration to Acutely Improve Landing Biomechanics In Individuals With Anterior Cruciate Ligament Reconstruction (ACLR)

Individuals who undergo anterior cruciate ligament reconstruction (ACLR) are at heightened risk of secondary anterior cruciate ligament (ACL) injury (e.g. additional injury to the ACL in either knee). One of the primary physiological consequences of ACLR is the presence of quadriceps dysfunction (i.e. reduced activation and strength) which has been linked to altered gait and landing biomechanics. Aberrant landing biomechanics have been associated with an increased risk of both primary and secondary ACL injury, thus additional research is needed to evaluate the efficacy of treatments aimed to reduce quadriceps dysfunction and restore adequate landing biomechanics in attempts to reduce secondary ACL injury. Whole-body Vibration (WBV) has demonstrated success in improving quadriceps function and gait biomechanics in individuals with ACLR, however its effectiveness on landing biomechanics is unknown. To evaluate the acute effects of WBV on landing biomechanics in those with ACLR, a non-randomized crossover-controlled trial was conducted to determine if a single bout of WBV improved landing biomechanics greater than a control condition. Participants completed two separate testing sessions (separated by at least one week) in which measures of quadriceps function and landing biomechanics were assessed before and after either a control (no WBV) or WBV intervention. Separate linear mixed-effects models of post-test values for each dependent outcome were conducted with condition (control vs WBV) and limb (ACLR vs Uninvolved) as an interaction term, and each condition pre-test values and time post-ACLR as fixed effect covariates and a random effect of subject. The investigators expect to observe a significant improvement in landing biomechanics following WBV compared to the control condition.

Being tested
Whole body vibration (WBV), Sham Whole body vibration
Keywords
vibration, quadriceps, secondary injury, ACL reconstruction, Landing biomechanics
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Whole body vibration (WBV)Other

    Participants will stand on a WBV platform in a mini-squat position while vibration is applied during six 60-second bouts with 2 minutes of rest between each bout. WBV will be delivered at an acceleration of 2g and a frequency of 30 Hz.

  • Sham Whole body vibrationOther

    Participants will stand on a WBV platform in a mini-squat position during six 60-second bouts with 2 minutes of rest between each bout. No vibration will be applied.

Study groups in NCT07681193
Study groupRoleWhat they receive
Whole body vibration followed by No Intervention (Control)ExperimentalParticipants in this arm will receive Whole Body Vibration followed by a washout period of 1 week, then receive the Sham Whole body vibration (Control). Each condition will be evaluated in a single session (i.e. acute effects).
Receives: Other: Whole body vibration (WBV); Other: Sham Whole body vibration
Sham Whole body vibration (Control) followed by Whole Body VibrationExperimentalParticipants in this arm will receive Sham Whole body vibration (Control) followed by a washout period of 1 week, then receive Whole Body Vibration. Each condition will be evaluated in a single session (i.e. acute effects).
Receives: Other: Whole body vibration (WBV); Other: Sham Whole body vibration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Internal Knee Adduction Moment (KAM)

    Peak value during landing in both single-leg and double-leg tasks averaged over 3 trials and normalized to the product of body weight and height

    Measured: Separate values prior to and immediately following the intervention (within 5 minutes).

  2. Internal Knee Extension Moment (KEM)

    Peak value during landing in both single-leg and double-leg tasks averaged over 3 trials and normalized to a product of body weight*height

    Measured: Separate values prior to and immediately following the intervention (within 5 minutes).

  3. Knee Flexion Angle (KFA)

    Peak value during landing in both single-leg and double-leg tasks averaged over 3 trials

    Measured: Separate values prior to and immediately following the intervention (within 5 minutes).

Secondary outcomes (3)
  1. Dynamic Postural Control

    Time-to-stabilization during single-leg landing

    Measured: Separate values prior to and immediately following the intervention (within 5 minutes).

  2. Vertical Ground Reaction Force

    Peak value during landing in both single-leg and double-leg tasks

    Measured: Separate values prior to and immediately following the intervention (within 5 minutes).

  3. Frontal Plane Kinematics

    Peak value during landing in both single-leg and double-leg tasks

    Measured: Separate values prior to and immediately following the intervention (within 5 minutes).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2026
  2. Study start1 Sep 2021
  3. Primary completion22 Apr 2022
  4. Study completion10 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07681193
Sponsor's protocol ID
21-0305
Status last verified
Jun 2026
First submitted
10 Jun 2026
Last updated
2 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified individual data that supports the results will be shared beginning 9 and continuing for 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Questions about this trial

What is this clinical trial studying?

A study testing Whole body vibration (WBV) in people with Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Tear, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Internal Knee Adduction Moment (KAM) (time frame: Separate values prior to and immediately following the intervention (within 5 minutes).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in